• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析 KMT2D 组蛋白赖氨酸甲基转移酶突变在膀胱癌中的作用。

Analysis of the role of mutations in the KMT2D histone lysine methyltransferase in bladder cancer.

机构信息

Department of Urology Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China.

Institute of Urology of Hubei Province Wuhan China.

出版信息

FEBS Open Bio. 2019 Feb 21;9(4):693-706. doi: 10.1002/2211-5463.12600. eCollection 2019 Apr.

DOI:10.1002/2211-5463.12600
PMID:30984543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6443872/
Abstract

Histone lysine methyltransferases (HMT) comprise a subclass of epigenetic regulators; dysregulation of these enzymes affects gene expression, which may lead to tumorigenesis. Here, we performed an integrated analysis of 50 HMTs in bladder cancer and found intrinsic links between copy number alterations, mutations, gene expression levels, and clinical outcomes. Through integrative analysis, we identified six HMT genes (,,,,, and ) that may play a key role in the development and progression of bladder cancer. Of these six HMTs, histone lysine -methyltransferase 2D () exhibited the highest mutation rate in bladder cancer. Our comparison of the mRNA and miRNA expression profiles of mutated and wild-type suggested that two signaling pathways (FOX1-miR-1224-5p-DLK1 and HIF/GATA5-miR-133a-3p-DRD5) may mediate the tumor suppressive effect of the mutation. In summary, our findings indicate that mutations in HMT genes, especially mutation, may play a role in the development of bladder cancer.

摘要

组蛋白赖氨酸甲基转移酶(HMT)属于表观遗传调控因子的一个亚类;这些酶的失调会影响基因表达,从而可能导致肿瘤发生。在这里,我们对膀胱癌中的 50 种 HMT 进行了综合分析,发现了拷贝数改变、突变、基因表达水平和临床结果之间的内在联系。通过综合分析,我们确定了六个可能在膀胱癌发生和发展中起关键作用的 HMT 基因(,,,,, 和 )。在这六个 HMT 中,组蛋白赖氨酸甲基转移酶 2D()在膀胱癌中的突变率最高。我们对突变型和野生型的 mRNA 和 miRNA 表达谱进行比较后发现,两条信号通路(FOX1-miR-1224-5p-DLK1 和 HIF/GATA5-miR-133a-3p-DRD5)可能介导了 突变的肿瘤抑制作用。总之,我们的研究结果表明,HMT 基因突变,尤其是 突变,可能在膀胱癌的发生中起作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e729/6443872/53d30fb1f4d9/FEB4-9-693-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e729/6443872/db0519e25451/FEB4-9-693-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e729/6443872/efe5fa514a58/FEB4-9-693-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e729/6443872/a07a38dbd6e4/FEB4-9-693-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e729/6443872/cfaba823baa0/FEB4-9-693-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e729/6443872/0bc60eedc75e/FEB4-9-693-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e729/6443872/8912ee3c9dd4/FEB4-9-693-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e729/6443872/53d30fb1f4d9/FEB4-9-693-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e729/6443872/db0519e25451/FEB4-9-693-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e729/6443872/efe5fa514a58/FEB4-9-693-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e729/6443872/a07a38dbd6e4/FEB4-9-693-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e729/6443872/cfaba823baa0/FEB4-9-693-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e729/6443872/0bc60eedc75e/FEB4-9-693-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e729/6443872/8912ee3c9dd4/FEB4-9-693-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e729/6443872/53d30fb1f4d9/FEB4-9-693-g007.jpg

相似文献

1
Analysis of the role of mutations in the KMT2D histone lysine methyltransferase in bladder cancer.分析 KMT2D 组蛋白赖氨酸甲基转移酶突变在膀胱癌中的作用。
FEBS Open Bio. 2019 Feb 21;9(4):693-706. doi: 10.1002/2211-5463.12600. eCollection 2019 Apr.
2
KMT2D inhibits the growth and metastasis of bladder Cancer cells by maintaining the tumor suppressor genes.KMT2D 通过维持肿瘤抑制基因抑制膀胱癌细胞的生长和转移。
Biomed Pharmacother. 2019 Jul;115:108924. doi: 10.1016/j.biopha.2019.108924. Epub 2019 May 14.
3
Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors.调控表观遗传学的基因的遗传突变状态:组蛋白甲基转移酶 KMT2D 在三阴性乳腺癌中的作用。
PLoS One. 2019 Apr 16;14(4):e0209134. doi: 10.1371/journal.pone.0209134. eCollection 2019.
4
Integrated Analysis of Genetic Abnormalities of the Histone Lysine Methyltransferases in Prostate Cancer.前列腺癌中组蛋白赖氨酸甲基转移酶遗传异常的综合分析。
Med Sci Monit. 2019 Jan 7;25:193-239. doi: 10.12659/MSM.912294.
5
KMT2C and KMT2D aberrations in breast cancer.乳腺癌中 KMT2C 和 KMT2D 的异常。
Trends Cancer. 2024 Jun;10(6):519-530. doi: 10.1016/j.trecan.2024.02.003. Epub 2024 Mar 7.
6
Genetic alterations of histone lysine methyltransferases and their significance in breast cancer.组蛋白赖氨酸甲基转移酶的基因改变及其在乳腺癌中的意义。
Oncotarget. 2015 Feb 10;6(4):2466-82. doi: 10.18632/oncotarget.2967.
7
MiRNA-217 accelerates the proliferation and migration of bladder cancer via inhibiting KMT2D.miRNA-217 通过抑制 KMT2D 促进膀胱癌的增殖和迁移。
Biochem Biophys Res Commun. 2019 Nov 19;519(4):747-753. doi: 10.1016/j.bbrc.2019.09.029. Epub 2019 Sep 20.
8
Small Cell Lung Cancer Exhibits Frequent Inactivating Mutations in the Histone Methyltransferase KMT2D/MLL2: CALGB 151111 (Alliance).小细胞肺癌在组蛋白甲基转移酶KMT2D/MLL2中频繁出现失活突变:CALGB 151111(联盟)。
J Thorac Oncol. 2017 Apr;12(4):704-713. doi: 10.1016/j.jtho.2016.12.011. Epub 2016 Dec 19.
9
Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene.全外显子组测序确定了嗜铬细胞瘤的突变图谱,并将KMT2D鉴定为一个反复突变的基因。
Genes Chromosomes Cancer. 2015 Sep;54(9):542-54. doi: 10.1002/gcc.22267. Epub 2015 May 29.
10
A Computational Approach to Predict the Role of Genetic Alterations in Methyltransferase Histones Genes With Implications in Liver Cancer.一种预测甲基转移酶组蛋白基因中的基因改变在肝癌中的作用的计算方法。
Cancer Inform. 2023 Mar 29;22:11769351231161480. doi: 10.1177/11769351231161480. eCollection 2023.

引用本文的文献

1
Integrative Analysis Reveals the Prognostic Effects of Epigenetic Regulators in Bladder Cancer.综合分析揭示表观遗传调控因子在膀胱癌中的预后作用。
Cancer Med. 2025 Jul;14(14):e71057. doi: 10.1002/cam4.71057.
2
Comprehensive multi-omics analysis of histone acetylation modulators identifies ASH1L as a novel aggressive marker for osteosarcoma.组蛋白乙酰化调节剂的综合多组学分析确定ASH1L为骨肉瘤的一种新型侵袭性标志物。
Discov Oncol. 2025 Jun 12;16(1):1070. doi: 10.1007/s12672-025-02920-6.
3
The utility of gene sequencing in identifying an underlying genetic disorder in prenatally suspected lower urinary tract obstruction.

本文引用的文献

1
KMT2D Mutation Is Associated With Poor Prognosis in Non-Small-Cell Lung Cancer.KMT2D 突变与非小细胞肺癌的不良预后相关。
Clin Lung Cancer. 2018 Jul;19(4):e489-e501. doi: 10.1016/j.cllc.2018.03.005. Epub 2018 Mar 16.
2
Genetic alterations and PIK3CA gene mutations and amplifications analysis in cervical cancer by racial groups in the United States.美国不同种族群体宫颈癌的基因改变及PIK3CA基因突变与扩增分析
Int J Health Sci (Qassim). 2018 Jan-Feb;12(1):28-32.
3
Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential.
基因测序在产前疑似下尿路梗阻中识别潜在遗传疾病的效用。
Prenat Diagn. 2024 Feb;44(2):196-204. doi: 10.1002/pd.6425. Epub 2023 Aug 18.
4
Epigenetic and Immunological Features of Bladder Cancer.膀胱癌的表观遗传和免疫学特征。
Int J Mol Sci. 2023 Jun 7;24(12):9854. doi: 10.3390/ijms24129854.
5
Chromatin Remodeling Enzyme Cluster Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Breast Cancer.染色质重塑酶簇预测乳腺癌的预后和治疗策略的临床获益。
Int J Mol Sci. 2023 Mar 15;24(6):5583. doi: 10.3390/ijms24065583.
6
Structure, activity and function of the lysine methyltransferase SETD5.赖氨酸甲基转移酶 SETD5 的结构、活性和功能。
Front Endocrinol (Lausanne). 2023 Feb 17;14:1089527. doi: 10.3389/fendo.2023.1089527. eCollection 2023.
7
Neurobehavioral characteristics of mice with mutations as models of IDD23 and KBG syndromes.具有作为IDD23和KBG综合征模型的突变的小鼠的神经行为特征。
Front Genet. 2023 Jan 4;13:1022339. doi: 10.3389/fgene.2022.1022339. eCollection 2022.
8
Mutational Landscape of Bladder Cancer in Mexican Patients: Mutations and chr11q15.5 Amplifications Are Associated with Muscle Invasion.墨西哥患者膀胱癌的突变全景:突变和 chr11q15.5 扩增与肌肉浸润相关。
Int J Mol Sci. 2023 Jan 6;24(2):1092. doi: 10.3390/ijms24021092.
9
The Role and Mechanism of microRNA-1224 in Human Cancer.微小RNA-1224在人类癌症中的作用及机制
Front Oncol. 2022 Apr 14;12:858892. doi: 10.3389/fonc.2022.858892. eCollection 2022.
10
CircRNA PTPRM Promotes Non-Small Cell Lung Cancer Progression by Modulating the miR-139-5p/SETD5 Axis.环状 RNA PTPRM 通过调控 miR-139-5p/SETD5 轴促进非小细胞肺癌进展。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221090090. doi: 10.1177/15330338221090090.
EZH2对癌症进展的表观遗传调控:从生物学见解到治疗潜力
Biomark Res. 2018 Mar 9;6:10. doi: 10.1186/s40364-018-0122-2. eCollection 2018.
4
Non-coding RNAs, epigenetics, and cancer: tying it all together.非编码 RNA、表观遗传学和癌症:将它们联系在一起。
Cancer Metastasis Rev. 2018 Mar;37(1):55-73. doi: 10.1007/s10555-017-9715-8.
5
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
6
Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer.表观遗传疗法将MYC缺失与逆转免疫逃逸及治疗肺癌联系起来。
Cell. 2017 Nov 30;171(6):1284-1300.e21. doi: 10.1016/j.cell.2017.10.022.
7
Histone H3 lysine 4 methyltransferase KMT2D.组蛋白H3赖氨酸4甲基转移酶KMT2D
Gene. 2017 Sep 5;627:337-342. doi: 10.1016/j.gene.2017.06.056. Epub 2017 Jun 29.
8
Activation of DRD5 (dopamine receptor D5) inhibits tumor growth by autophagic cell death.DRD5(多巴胺受体 D5)的激活通过自噬性细胞死亡抑制肿瘤生长。
Autophagy. 2017 Aug 3;13(8):1404-1419. doi: 10.1080/15548627.2017.1328347. Epub 2017 Jun 14.
9
Ezh2 Acts as a Tumor Suppressor in Kras-driven Lung Adenocarcinoma.Ezh2在Kras驱动的肺腺癌中发挥肿瘤抑制作用。
Int J Biol Sci. 2017 May 16;13(5):652-659. doi: 10.7150/ijbs.19108. eCollection 2017.
10
Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset.膀胱癌分子亚型的遗传改变:癌症基因组图谱数据集的说明。
Eur Urol. 2017 Sep;72(3):354-365. doi: 10.1016/j.eururo.2017.03.010. Epub 2017 Mar 30.